Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease

European Archives of Psychiatry and Clinical Neuroscience

Volumn 246, Issue 3, 1996, Pages 129-131

  Gattaz, W F ^a   Cairns, N J ^b   Levy, R ^b   Forstl H ^a   Braus, D F ^a   Maras, A ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Brain phospholipids; Phospholipase A2; Platelets; amyloid

Indexed keywords

PHOSPHOLIPASE A; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MEMBRANE PHOSPHOLIPID; PHOSPHOLIPASE A2;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD; BRAIN; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; NEUROFIBRILLARY TANGLE; ONSET AGE; PARIETAL LOBE; PATHOLOGY; PREFRONTAL CORTEX; THROMBOCYTE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FRONTAL CORTEX; HUMAN CELL; HUMAN TISSUE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; SENILE PLAQUE; SHORT SURVEY;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD PLATELETS; BRAIN; FEMALE; HUMANS; MALE; NEUROFIBRILLARY TANGLES; PARIETAL LOBE; PHOSPHOLIPASES A; PREFRONTAL CORTEX;

EID: 0029666106     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bazan HEP, Ridneour B, Birkle DL, Bazan NG (1986) Unique metabolic features of docosahexanoate metabolism related to functional roles in brain and retina. In: Horroks LA, Freysz L, Toffano G (eds) Phospholipid research and the nervous system. Biochemical and molecular pharmacology. Fidia Research Series, vol 4. Liviana Press, Padova, pp 67-78
2. Brown GG, Levine SR, Gorell JM, Pettegrew JW, Gdowski JW, Bueri JA, Helpern JA, Welch KMA (1989) In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 39 : 1423-1427
3. Coporaso GL, Gandy SE, Buxbaum JD, Ramabhadran TV, Greengard P (1992) Protein phosphorylation regulated secretion of Alzheimer βA4 amyloid precursor protein. Proc Natl Acad Sci USA 89 : 3055-3059
4. Dyrks T, Weidermann A, Multhaup G, Salbaum JM, Lemaire HG, Kang J, Buller-Hill B, Masters CL, Beyreuther K (1988) Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J 7 : 949-957
5. 2 activation influences the processing and secretion of the amyloid precursor protein. Biochem Biophys Res Commun 197 : 292-297
6. Farooqui AA, Liss L, Horroks LA (1990) Elevated activities of lipases and lysophospholipase in Alzheimer's disease. Dementia 1 : 208-214
7. Folstein M, Folstein S, McHugh P (1975) Mini-Mental State. J Psychiatr Res 12 : 189-198
8. Förstl H, Burns A, Levy R, Cairns N, Luthert P, Lantos P (1992) Neurologic signs in Alzheimer's disease: results of a prospective clinical and neuropathologic study. Arch Neurol 49 : 1038-1042
9. 5 activity in Alzheimer brains. Biol Psychiatry 37 : 13-17
10. Gattaz WF, Schmitt A, Maras A (1995 b) Increased platelet phospholipase AT activity in schizophrenia. Schizophr Res 16 : 1-6
11. Kanfer JN, Hattori H, Orihel D (1986) Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patients. Ann Neurol 20 : 265-267
12. 2. J Biol Chem 266 : 14850-14853
13. Skinner ER, Watt C, Besson JAO, Best PV (1989) Lipid composition of different regions of the brain in patients with Alzheimer's disease. Biochem Soc Trans 17 : 213-214
14. Smith RP, Higuschi DA, Broze GJ Jr (1990) Platelet coagulation factor lxa-inhibitor, a form of Alzheimer amyloid precursor protein. Science 248 : 1126-1128